300194.SZ
Fuan Pharmaceutical (Group) Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 3.91
−0.51%Year over year
Reported trailing growth
- Revenue
- -18.1%
- EBITDA
- —
- EBIT
- -71.6%
- EPS
- -66.2%
- Free cash flow
- +623.8%
- Operating cash flow
- +110.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -10.5%
- EBITDA
- -7.3%
- EBIT
- -22.2%
- Net income
- -27.8%
- EPS
- -29.3%
- Free cash flow
- +34.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026